NREP
NEW REPRESENTATIVE AT IB RECEIVED
09/10/2025
Voltar para busca
Dado oficial do USPTO
BIFIBABY
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
52
Atualização mais recente
10/10/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5
Data de depósito
27/09/2008
Data de registro
08/12/2009
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
26/02/2021
Última transação
10/10/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
09
Localização do titular
IT
Examinador
HABEEB,MYRIAH A
Unidade examinadora
L50
Titulares e representantes
Titulares
PROBIOTICAL S.P.A.
PROBIOTICAL SPA
Representantes
JOHN P. MURTAUGH PEARNE & GORDON LLP
Classificação técnica
Classes Nice
Classe 1Classe 5
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Fermentation extracts and bacteria for use in food manufacturemicro-organisms and cultures of micro-organismsin particular bacteriabifid bacteriayeast and fermented milk productsfermentation extracts and bacteria for use in food manufacturemicro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria to be administered to human beings and reared animal speciesnot for medical or veterinary usefermentation extracts and bacteria for use in food manufacturemicro-organisms and concentrated cultures of probiotic micro-organisms in liquidsoliddried and freeze-dried form
Classe 5
Bacterial and bacteriological preparations for medical or veterinary purposesmicro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria to be administered to human beings and reared animal speciesbacterial and bacteriological preparations for medical or veterinary purposesmicro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria which * anallergic probiotic bifid bacteria which has beneficial activity on the intestinal microflora of babies * cause a metabolic effect that may affect cholesterols levels in the bloodproprietary medicine containing micro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria for treating the intestinal bacterial florafor restoring the balance of the intestinal bacterial flora when changed in the course of treatment with antibiotics or chemotherapyfor treating acute and chronic gastro-intestinal diseases caused by a change in the intestinal bacterial florafor treating intestinal dismicrobic syndromesdiseases linked to changes in the bacterial floradiarrheagastroenteritisnon-specific enteritiscolitisulcerous colitis and Crohn's diseaseto be taken orallyin particular in the pharmaceutical form of capsulestabletssolutionssuspensionsgranules and granules in dried or freeze-dried formfood supplementsfood supplements for medical use containing micro-organisms or cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria to be administered to human beingsdietary supplementsfood supplements containing micro-organisms and cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria to be administered to human beings and reared animal speciesnot for medical or veterinary usesymbiotic supplementsdietary supplementscontaining micro-organisms or cultures of micro-organismsin particular probiotic lactic bacteriaprobiotic bifid bacteria and prebiotic fibresfood supplements for animalsnot for medical use
Publicações
Histórico de despachos e eventos da marca no USPTO.
52 publicações encontradas
NREP
NEW REPRESENTATIVE AT IB RECEIVED
08/04/2022
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
14/01/2022
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
17/12/2021
INPC
INVALIDATION PROCESSED
17/12/2021
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
26/10/2021
C71T
CANCELLED SECTION 71
26/02/2021
REM4
COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED
08/12/2018
RNWL
INTERNATIONAL REGISTRATION RENEWED
11/10/2018
INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
07/07/2017
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
10/05/2017
INPC
INVALIDATION PROCESSED
10/05/2017
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
09/05/2017
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
17/02/2017
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/09/2016
71.P
REGISTERED - PARTIAL SEC 71 ACCEPTED
09/09/2016
EROP
TEAS RESPONSE TO OFFICE ACTION-POST REG RECEIVED
29/08/2016
PR71
POST REGISTRATION ACTION MAILED - SEC.71
13/07/2016
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
11/07/2016
ES71
TEAS SECTION 71 RECEIVED
03/06/2016
NREP
NEW REPRESENTATIVE AT IB RECEIVED
26/02/2015
NREP
NEW REPRESENTATIVE AT IB RECEIVED
27/11/2014
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/01/2013
NREP
NEW REPRESENTATIVE AT IB RECEIVED
25/06/2011
FICS
FINAL DISPOSITION NOTICE SENT TO IB
24/03/2010
FIMP
FINAL DISPOSITION PROCESSED
24/03/2010
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
08/03/2010
CORR
CORRECTION FROM IB ENTERED - NO REVIEW REQUIRED
25/02/2010
COC.
CORRECTION UNDER SECTION 7 - PROCESSED
24/02/2010
PLGL
ASSIGNED TO PARALEGAL
24/02/2010
R.PR
REGISTERED-PRINCIPAL REGISTER
08/12/2009
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
30/10/2009
PUBO
PUBLISHED FOR OPPOSITION
22/09/2009
NPUB
NOTICE OF PUBLICATION
02/09/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
20/08/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/08/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
29/07/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
29/07/2009
ALIE
ASSIGNED TO LIE
29/07/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
13/07/2009
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/07/2009
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/07/2009
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/07/2009
RFNT
REFUSAL PROCESSED BY IB
06/02/2009
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
13/01/2009
RFRR
REFUSAL PROCESSED BY MPU
13/01/2009
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
13/01/2009
MAFR
APPLICATION FILING RECEIPT MAILED
13/01/2009
CNRT
NON-FINAL ACTION WRITTEN
12/01/2009
DOCK
ASSIGNED TO EXAMINER
07/01/2009
NWAP
NEW APPLICATION ENTERED
07/01/2009
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
06/01/2009
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace BIFIBABY ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.